| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of FGF9 mRNA" | 19358281 |
| C046760 | 15-acetyldeoxynivalenol | 15-acetyldeoxynivalenol results in increased expression of FGF9 mRNA | 23792671 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | 20464547 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | 20464547 |
| C038890 | 2,3,4,7,8-pentachlorodibenzofuran | "2,3,4,7,8-pentachlorodibenzofuran results in increased expression of FGF9 mRNA" | 19358281 |
| C006551 | 2-amino-2-methyl-1-propanol | 2-amino-2-methyl-1-propanol results in decreased expression of FGF9 mRNA | 25088246 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FGF9 mRNA" | 19358281 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FGF9 mRNA" | 23196670 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | 20464547 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | 20464547 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of FGF9 gene | 27153756 |
| D019386 | Alendronate | Alendronate affects the expression of FGF9 mRNA | 16079270 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of FGF9 mRNA | 16483693 |
| D000735 | Androstenedione | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Androstenedione]] | 22872763 |
| D000735 | Androstenedione | FGF9 protein inhibits the reaction [[LHB protein co-treated with IGF1 protein] results in increased abundance of Androstenedione] | 22872763 |
| D000735 | Androstenedione | FGF9 protein inhibits the reaction [LHB protein results in increased abundance of Androstenedione] | 22872763 |
| D001151 | Arsenic | Arsenic affects the methylation of FGF9 gene | 25304211 |
| C547126 | AZM551248 | AZM551248 results in decreased expression of FGF9 mRNA | 22323515 |
| C487081 | belinostat | belinostat results in decreased expression of FGF9 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of FGF9 mRNA | 19358281 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of FGF9 mRNA | 26377693 |
| C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased expression of FGF9 mRNA | 19358281 |
| D001564 | Benzo(a)pyrene | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | 20464547 |
| D001564 | Benzo(a)pyrene | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene results in increased expression of FGF9 mRNA] | 20464547 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FGF9 mRNA | 16002475|1935828 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FGF9 protein | 20464547 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of FGF9 mRNA | 23735875 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FGF9 mRNA" | 20382639 |
| D004958 | Estradiol | Estradiol results in increased expression of FGF9 mRNA | 12072406|1460280 |
| D004958 | Estradiol | Estradiol results in increased expression of FGF9 protein | 12072406 |
| D004958 | Estradiol | [FGF9 protein co-treated with FSHB protein] affects the abundance of Estradiol | 22798350 |
| D004958 | Estradiol | FGF9 protein inhibits the reaction [Bucladesine promotes the reaction [IGF1 protein results in increased abundance of Estradiol]] | 22798350 |
| D004958 | Estradiol | FGF9 protein inhibits the reaction [Colforsin promotes the reaction [IGF1 protein results in increased abundance of Estradiol]] | 22798350 |
| D004958 | Estradiol | FGF9 protein inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased abundance of Estradiol] | 22798350 |
| D004958 | Estradiol | FGF9 protein inhibits the reaction [IGF1 protein results in increased abundance of Estradiol] | 22798350 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of FGF9 mRNA | 17404688 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of FGF9 mRNA | 27685785 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of FGF9 mRNA | 22732146 |
| C006780 | bisphenol A | bisphenol A results in increased expression of FGF9 mRNA | 27022677 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of FGF9 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of FGF9 gene | 28505145 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FGF9 mRNA | 22079614 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of FGF9 mRNA | 26079696 |
| C584509 | C646 compound | C646 compound results in increased expression of FGF9 mRNA | 26191083 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of FGF9 mRNA | 17720352 |
| D002118 | Calcium | Calcium affects the expression of FGF9 mRNA | 15913539 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of FGF9 protein | 17662249 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of FGF9 mRNA | 26272509 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of FGF9 mRNA | 20350560 |
| D004390 | Chlorpyrifos | Chlorpyrifos affects the expression of FGF9 mRNA | 18502319 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of FGF9 mRNA | 24374135 |
| C031180 | chrysene | chrysene results in increased expression of FGF9 mRNA | 26377693 |
| D005576 | Colforsin | FGF9 protein inhibits the reaction [Colforsin promotes the reaction [IGF1 protein results in increased abundance of Estradiol]] | 22798350 |
| D005576 | Colforsin | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Colforsin results in increased abundance of Progesterone]] | 22798350 |
| D000069439 | Dasatinib | Dasatinib results in increased expression of FGF9 mRNA | 20579391 |
| D003976 | Diazinon | Diazinon affects the expression of FGF9 mRNA | 19130878|2254681 |
| D003994 | Bucladesine | FGF9 protein inhibits the reaction [Bucladesine results in increased abundance of Progesterone] | 22872763 |
| D003994 | Bucladesine | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Androstenedione]] | 22872763 |
| D003994 | Bucladesine | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]] | 22872763 |
| D003994 | Bucladesine | FGF9 protein inhibits the reaction [Bucladesine promotes the reaction [IGF1 protein results in increased abundance of Estradiol]] | 22798350 |
| D003994 | Bucladesine | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]] | 22798350 |
| D003994 | Bucladesine | FGF9 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone] | 22798350 |
| D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of FGF9 mRNA | 28962523 |
| D002945 | Cisplatin | FGF9 protein affects the susceptibility to Cisplatin | 16217747 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of FGF9 mRNA | 26924002 |
| D004026 | Dieldrin | Dieldrin affects the expression of FGF9 mRNA | 22546817 |
| D004026 | Dieldrin | Dieldrin results in increased expression of FGF9 mRNA | 19130878 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of FGF9 protein | 27060630 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of FGF9 mRNA | 28123099 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in decreased expression of FGF9 mRNA | 26924002 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of FGF9 mRNA | 20146380 |
| D004317 | Doxorubicin | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of FGF9 mRNA | 21040762 |
| C118739 | entinostat | entinostat results in decreased expression of FGF9 mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| D004967 | Estrogens | FGF9 protein promotes the reaction [Estrogens results in increased expression of TBX3 protein] | 21098263 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of FGF9 mRNA | 16079270 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of FGF9 mRNA | 16551644 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of FGF9 mRNA | 23550701 |
| C070081 | fulvestrant | fulvestrant results in decreased expression of FGF9 mRNA | 14602803 |
| D005944 | Glucosamine | Glucosamine inhibits the reaction [IL1B results in increased expression of FGF9 mRNA] | 17109745 |
| D005944 | Glucosamine | Glucosamine results in increased expression of FGF9 mRNA | 17109745 |
| C492448 | ICG 001 | ICG 001 results in increased expression of FGF9 mRNA | 26191083 |
| C051890 | irinotecan | irinotecan analog results in decreased expression of FGF9 mRNA | 18927307 |
| C004809 | isopentenyl pyrophosphate | isopentenyl pyrophosphate results in increased expression of FGF9 mRNA | 14704367 |
| C004809 | isopentenyl pyrophosphate | isopentenyl pyrophosphate results in increased expression of FGF9 protein | 14704367 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of FGF9 protein" | 23604539 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of FGF9 protein]" | 23604539 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in decreased expression of FGF9 mRNA" | 19524256 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of FGF9 mRNA | 12057914 |
| D008070 | Lipopolysaccharides | "[Lipopolysaccharides co-treated with Thymic Factor, Circulating co-treated with Zinc] results in increased expression of FGF9 protein" | 12639846 |
| D008550 | Melatonin | Melatonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FGF9 mRNA] | 19476551 |
| D008550 | Melatonin | Melatonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FGF9 protein] | 19476551 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of FGF9 mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of FGF9 mRNA | 23179753|2718838 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of FGF9 mRNA | 19476551 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of FGF9 protein | 19476551 |
| D015655 | 1-Methyl-4-phenylpyridinium | Melatonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FGF9 mRNA] | 19476551 |
| D015655 | 1-Methyl-4-phenylpyridinium | Melatonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of FGF9 protein] | 19476551 |
| D015655 | 1-Methyl-4-phenylpyridinium | FGF9 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium | 19476551 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of FGF9 mRNA | 26924002 |
| D009151 | Mustard Gas | IL10 protein affects the reaction [Mustard Gas affects the expression of FGF9 mRNA] | 16173061 |
| C002701 | neocuproine | "neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of FGF9 protein]" | 23604539 |
| C007350 | nitrofen | nitrofen results in decreased expression of FGF9 mRNA | 23897418 |
| C007350 | nitrofen | nitrofen results in decreased expression of FGF9 protein | 23897418 |
| D010126 | Ozone | Ozone results in decreased expression of FGF9 mRNA | 12763052 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in decreased expression of FGF9 mRNA | 26272509 |
| D052638 | Particulate Matter | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | 20464547 |
| D052638 | Particulate Matter | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Particulate Matter results in increased expression of FGF9 mRNA] | 20464547 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of FGF9 mRNA | 20464547 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of FGF9 protein | 20464547 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of FGF9 mRNA | 26272509 |
| D010672 | Phenytoin | Phenytoin results in increased expression of FGF9 mRNA | 14741686 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of FGF9 mRNA | 21297082 |
| D000072317 | Polychlorinated Dibenzodioxins | Polychlorinated Dibenzodioxins results in increased expression of FGF9 mRNA | 19358281 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons results in increased expression of FGF9 mRNA | 16002475|2046454 |
| D011084 | Polycyclic Aromatic Hydrocarbons | Polycyclic Aromatic Hydrocarbons results in increased expression of FGF9 mRNA | 16002475 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in decreased expression of FGF9 mRNA | 23608068 |
| D011284 | Pregnenolone | FGF9 protein inhibits the reaction [[FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone] | 22798350 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [Bucladesine results in increased abundance of Progesterone] | 22872763 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]] | 22872763 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [IGF1 protein results in increased abundance of Progesterone] | 22872763 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [[LHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone] | 22872763 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [LHB protein results in increased abundance of Progesterone] | 22872763 |
| D011374 | Progesterone | FGF9 protein results in decreased abundance of Progesterone | 22872763 |
| D011374 | Progesterone | [FGF9 protein co-treated with FSHB protein] affects the abundance of Progesterone | 22798350 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased abundance of Progesterone] | 22798350 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone]] | 22798350 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [IGF1 protein promotes the reaction [Colforsin results in increased abundance of Progesterone]] | 22798350 |
| D011374 | Progesterone | FGF9 protein inhibits the reaction [IGF1 protein results in increased abundance of Progesterone] | 22798350 |
| D011374 | Progesterone | FGF9 protein promotes the reaction [Bucladesine results in increased abundance of Progesterone] | 22798350 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of FGF9 mRNA | 17404688 |
| D011374 | Progesterone | Progesterone results in decreased expression of FGF9 mRNA | 22238285 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of FGF9 mRNA | 24780913 |
| C043680 | ptaquiloside | ptaquiloside results in decreased expression of FGF9 mRNA | 23274088 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of FGF9 mRNA | 16079270 |
| D012999 | Soman | Soman results in increased expression of FGF9 mRNA | 19281266 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF9 protein results in increased phosphorylation of MAPK1 protein] | 16150908 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [FGF9 protein results in increased phosphorylation of MAPK3 protein] | 16150908 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of FGF9 mRNA | 24769059 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGF9 mRNA | 19358281|2010694 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of FGF9 mRNA | 26377647 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of FGF9 mRNA | 21602191 |
| D013974 | Thyroxine | Thyroxine results in increased expression of FGF9 mRNA | 22798350 |
| D013935 | Thymic Factor, Circulating | "[Lipopolysaccharides co-treated with Thymic Factor, Circulating co-treated with Zinc] results in increased expression of FGF9 protein" | 12639846 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of FGF9 mRNA | 20464547 |
| D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of FGF9 protein | 24096154 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution deficiency inhibits the reaction [[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of FGF9 protein] | 24096154 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of FGF9 protein | 27793746 |
| C483909 | torcetrapib | torcetrapib results in increased expression of FGF9 mRNA | 23228038 |
| D014212 | Tretinoin | Tretinoin results in increased expression of FGF9 mRNA | 21934132 |
| D014212 | Tretinoin | Tretinoin results in increased expression of FGF9 mRNA | 15621532|7656983 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of FGF9 mRNA | 24935251|2627250 |
| C012589 | trichostatin A | trichostatin A results in increased expression of FGF9 mRNA | 24935251 |
| C009954 | trilostane | FGF9 protein inhibits the reaction [[FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone] | 22798350 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of FGF9 mRNA | 23179753|2438349 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in decreased expression of FGF9 mRNA | 17459161 |
| D014640 | Vancomycin | Vancomycin results in increased expression of FGF9 mRNA | 18930951 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of FGF9 mRNA | 26682919 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in decreased expression of FGF9 mRNA | 26272509 |
| D015032 | Zinc | "[Lipopolysaccharides co-treated with Thymic Factor, Circulating co-treated with Zinc] results in increased expression of FGF9 protein" | 12639846 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of FGF9 mRNA | 24714768 |